Search Filters

Search Results

Found 18 results

510(k) Data Aggregation

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    Tested chemotherapy drugs are as follows:

    Test Chemotherapy drug & ConcentrationAverage Breakthrough Detection Time (Minutes)
    Carmustine (BCNU)(3.3 mg/ml)12.1 min.
    Cyclophosphamide (Cytoxan) (20.0 mg/ml)>240 min.
    Doxorubicin Hydrichloride (2.0mg/)>240 min.
    Etoposide (Toposar) (20.0mg/ml)>240 min.
    Fluorouracil (50.0mg/ml)>240 min.
    Methotrexate (25.0 mg/ml)>240 min.
    Paclitaxel (Taxol) (6.0 mg/ml)>240 min.
    Thiotepa(10.0 mg/ml)10.1 min.
    Vincristine Sulfate(1.0 mg/ml)>240 min.
    Cisplatin(1.0 mg/ml)>240 min.
    Dacarbazine(10 mg/ml)>240 min.
    Mitomycin C(0.5 mg/ml)>240 min.

    Please note that the following drugs have extremely low permeation times: Carmustine (BCNU): 12.1 minutes and Thiotepa:10.1 minutes.

    Warning: Do not use with Carmustine or Thiotepa

    Fentanyl Citrate & ConcentrationMinimum Breakthrough Detection Times
    Fentanyl Citrate Injection(100 mcg/2ml)>240 min.
    Device Description

    The Nitrile Patient Examination Gloves with Hyaluronic Acid Blue Colored and Tested for Use with Chemotherapy Drugs and Fentanyl citrate. Aka Synguard C+ Nitrile Exam Gloves are non-sterile, single use only, disposable, powder free examination gloves. The glove is made of nitrile butadiene rubber. Chlorination is applied to the inner surface of the glove to make donning easy. Characteristic:

    • Ambidextrous with beaded cuff and straight fingers
    • Finger-textured,
    • Blue colored
    • Containing Hyaluronic Acid coating.
    • Six (6) sizes extra-small, small, medium, large, extra-large and XXL.
    • Tested against chemotherapy drugs and fentanyl citrate.

    The gloves are designed to meets the specifications of ASTM D6319-19, Standard Specification for Nitrile Examination Gloves for Medical Application.

    AI/ML Overview

    The provided document is a 510(k) summary for a medical device (nitrile patient examination gloves with hyaluronic acid) and details the performance testing against established standards.

    Here's a breakdown of the acceptance criteria and study information, based on the provided text:

    1. A table of acceptance criteria and the reported device performance:

    The document includes a "Technological Characteristics Comparison Table" (pages 7-9) that serves this purpose. It compares the applicant's device to a predicate device (K200671). The "Acceptance Criteria" column effectively outlines the criteria, and the "Anhui Intco Medical Products Co., Ltd. Nitrile Patient Examination Gloves..." column shows the reported device performance.

    CharacteristicsAcceptance Criteria (from predicate/standards)Reported Device Performance (Anhui Intco Medical Products Co., Ltd.)Comparison Conclusions
    Product CodeLZA, LZC, OPJ, QDOLZA, LZC, OPJ, QDO(Implicitly "Same")
    Intended useA powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs as per ASTM D6978-05.A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.Same
    Material usedNitrileNitrileIdentical
    ColorBlueBlueSame
    Single useSingle UseYesSame
    Non SterileNon SterileNon SterileSame
    Other(Implicit: Additives related to coating)Hyaluronic Acid coated on the donning surfaceDifferent(1)
    DimensionsOverall Length (mm): For XS, S, Min 220mm; For M,L,XL,XXL Min 230mm. Width (± 10mm): XS=70mm, S=80mm, M=95mm, L=110mm, XL=120mm, XXL=130mm. Thickness at Palm (mm) Min: 0.05mm. Thickness at Finger Tip (mm) Min: 0.05mm.Complies with ASTM D6319-19: X Small 70±10, Small 80 ±10, Medium 95±10, Large 110 ±10, X large 120 ±10, XX Large 130 ±10. Thickness: Palm - 0.05mm min., Finger - 0.05 mm min.Similar
    Physical propertiesBefore Ageing: Tensile Strength (MPa) = 14min, Ultimate Elongation (%) = 500min. After Aging: Tensile Strength (MPa) = 14min, Ultimate Elongation (%) = 400min.Meets ASTM D6319-19: Tensile Strength: Before Aging 14 MPa, min. After Aging 14 MPa, min. Elongation: Before Aging 500% min. After Aging 400% min.Meets the criteria
    Freedom from pinholesAQL 2.5, Inspection Level G-1In accordance with ASTM D6319-19 and ASTM D5151-19, G-1, AQL 2.5Meets the criteria
    Residual PowderLess than 2mg per glove ASTM D 6124-06Average powder residue < 2mg per gloveMeets the criteria
    Primary Skin Irritation TestISO10993-10:2010Under the conditions of this study, the test article was a non-irritant.Same
    Dermal Sensitization AssayISO10993-10:2010Under the conditions of this study, the test article was a non-sensitizer.Same
    Acute systemic toxicityISO 10993-11:2017Under the conditions of this study, No evidence of acute systemic toxicitySame
    Resistance against Chemotherapy DrugsStandards Practice for Assessment of resistance of Medical Glove to Permeation by Chemotherapy drugs ASTM D6978-05(2013)1) Carmustine (BCNU) (3.3 mg/ml), Breakthrough time: 12.1 min.2) Cyclophosphamide (Cytoxan), (20.0 mg/ml), Breakthrough time: >240 min.3) Doxorubicin Hydrochloride (2.0mg/), Breakthrough time: >240 min.4) Etoposide (Toposar) (20.0mg/ml), Breakthrough time: >240 min.5) Fluorouracil (50.0mg/ml), Breakthrough time:>240 min.6) Methotrexate (25.0 mg/ml), Breakthrough time: >240 min.7) Paclitaxel (Taxol) (6.0 mg/ml), Breakthrough time: >240 min.8) Thiotepa, Breakthrough time: 10.1 min.9) Vincristine Sulfate (1.0 mg/ml), Breakthrough time:>240 min.10) Cisplatin (1.0 mg/ml), Breakthrough time:>240 min.11) Dacarbazine (10 mg/ml), Breakthrough time:>240 min.12) Mitomycin C (0.5 mg/ml), Breakthrough time:>240 min.13) Fentanyl Citrate Injection (100 mcg/2ml), Breakthrough time:>240 min.Similar

    2. Sample size used for the test set and the data provenance:

    The document does not explicitly state the sample sizes for the test sets in the non-clinical tests (e.g., how many gloves were tested for pinholes, how many animals were used for biocompatibility testing). However, it refers to industry standards like ASTM and ISO, which typically define appropriate sample sizes for such tests.

    • Provenance: The tests were performed in accordance with international standards (ASTM, ISO). The manufacturing company is Anhui Intco Medical Products Co., Ltd. located in Anhui, China. The testing itself is presented as non-clinical testing to demonstrate performance against these standards. The testing format suggests a retrospective evaluation against pre-defined performance criteria.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):

    This information is not applicable as the document describes performance testing of physical characteristics of gloves against codified standards (ASTM, ISO), not an AI device or a diagnostic device requiring expert interpretation of results to establish ground truth. The "ground truth" here is the pass/fail criteria defined by the standards.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

    This is not applicable as the document describes performance testing of physical characteristics against codified standards. There is no subjective adjudication process for the test results.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    This is not applicable. The device is a medical glove, not an AI-assisted diagnostic tool.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

    This is not applicable. The device is a medical glove, not an algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):

    The "ground truth" for the performance tests conducted (e.g., tensile strength, pinholes, chemical permeation, biocompatibility) is established by industry standards and test methods (ASTM D6319-19, ASTM D5151-19, ASTM D6124-06, ASTM D6978-05, ISO 10993 series). These standards define the acceptable range or threshold for a given characteristic to be considered compliant.

    8. The sample size for the training set:

    This is not applicable. The device is a medical glove, not an AI model that requires a training set.

    9. How the ground truth for the training set was established:

    This is not applicable.

    Ask a Question

    Ask a specific question about this device

    K Number
    K222103
    Date Cleared
    2023-08-24

    (402 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination glove is a disposable device intended for medical purposes that is worn upon the examiner's hands or fingers to prevent contamination between patient and examiner.

    Device Description

    The subject device in this 510(k) Notification is Nitrile Patient Examination Gloves, Powder Free, Pink Color. The subject device is a patient examination glove made from nitrile compound, pink color, powder free and non-sterile (Per 21 CFR 880.6250, class I). These gloves are pink in color and are powder free. The gloves are ambidextrous single use disposable devices that come in six sizes (XS, S, M, L, XL and XXL).

    AI/ML Overview

    The provided text describes the acceptance criteria and the study results for the "Nitrile Patient Examination Gloves, Powder Free, Pink Color" manufactured by Shandong YINGHONG Medical Products Co., Ltd.

    Here's the breakdown of the requested information:

    1. A table of acceptance criteria and the reported device performance

    Test Method (Purpose)Acceptance CriteriaReported Device Performance (Results)
    Dimensions (length, width, thickness) (ASTM D6319-19) - To evaluate the physical dimension of the gloveLength: 220 mm min (XS, S); 230 mm min (M, L, XL, XXL)Pass (240 mm min)
    Width (mm): XS: 70±10; S: 80±10; M: 95±10; L: 110±10; XL: 120±10; XXL: 130±10Pass (XS: average 78.4mm; S: average 86.2mm; M: average 97.4mm; L: average 108.7mm; XL: average 115.5mm; XXL: average 123.5mm)
    Thickness(mm): Palm: Minimum 0.05; Finger: Minimum 0.05Pass (Palm - 0.056mm min.; Finger - 0.082mm min)
    Physical properties (ASTM D6319-19) - To evaluate the tensile strength and ultimate elongation before and after agingBefore Aging: Tensile Strength: 14 MPa, min.; Elongation: 500%, min. After Aging: Tensile Strength: 14 MPa, min.; Elongation: 400%, min.Pass (Before Aging: Tensile Strength: 20.6MPa, min.; Elongation: 531%, min. After Aging: Tensile Strength: 21.9MPa, min.; Elongation: 416%, min.)
    Freedom from holes (ASTM D5151-19) - To detect holes in the glovesIn accordance with ASTM D6319-19 and ASTM D5151-19, G-1, AQL 2.5 (Implicit in "Similar" comparison to predicate)(The specific result for this test is not explicitly stated in the table provided for the subject device, but the comparison table indicates "Similar" to the predicate which met these standards)
    Residual Powder (ASTM D6124-06) - To detect the powder residue in the glove<2mg per glovePass (Average 0.15 mg per glove)
    In Vitro Cytotoxicity Test (ISO 10993-5) - To determine the cytotoxic potential of the glove.Under the conditions of the study, the device is not cytotoxicPass (Under the conditions of the study, the device have no cytotoxic effect)
    Skin Sensitization Test (ISO 10993-10) - To determine the skin sensitization potential of the glove.Under the conditions of the study, the device is not a sensitizerPass (Under the conditions of the study, the device is not a sensitizer.)
    Skin Irritation Test (ISO 10993-10) - To determine the potential of the glove under test to produce irritation.Under the conditions of the study, the device is not an irritantPass (Under the conditions of the study, the device is not an irritant.)

    2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    The document primarily discusses non-clinical physical and biocompatibility testing. It cites compliance with ASTM and ISO standards for these tests. For these types of tests, specific sample sizes beyond what the standards prescribe are usually not detailed in the summary. For example, ASTM D6319-19 and ASTM D5151-19 would define the sampling plans. The document mentions "Three Lot" for the residual powder test, suggesting at least three batches were sampled.

    The data provenance is from the manufacturer, Shandong YINGHONG Medical Products Co., Ltd., which is located in Qingzhou, Shandong, China. The studies are prospective as they are conducted for the specific purpose of device submission and evaluation against standards.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This information is not applicable as the device is a patient examination glove and the tests performed are physical and biocompatibility evaluations against established industry standards (ASTM, ISO). These do not involve human interpretation or expert-established ground truth in the way medical imaging or diagnostics might. The "ground truth" is defined by the objective measurement specifications of the standards.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This information is not applicable for the same reasons as point 3. Physical and biocompatibility tests are objective and do not typically involve adjudication.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This information is not applicable. The device is an examination glove, not an AI-assisted diagnostic tool.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

    This information is not applicable. The device is an examination glove, not an algorithm.

    7. The type of ground truth used (expert concensus, pathology, outcomes data, etc)

    The "ground truth" for the performance evaluation of these gloves is based on established industry standards and regulatory specifications as outlined in ASTM D6319-19, ASTM D6124-06, ASTM D5151-19, ISO 10993-10, and ISO 10993-5. This is objective and measurable, rather than relying on expert consensus or pathology in a clinical diagnostic sense.

    8. The sample size for the training set

    This information is not applicable. There is no "training set" in the context of physical and biocompatibility testing of a medical device like an examination glove. These tests are direct evaluations against performance criteria.

    9. How the ground truth for the training set was established

    This information is not applicable as there is no training set for this type of device and testing.

    Ask a Question

    Ask a specific question about this device

    K Number
    K221747
    Date Cleared
    2022-12-01

    (168 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The nitrile examination glove is intended to be worn on the examiner's hand to prevent contamination between patient and examiner. This is a single-use, powder-free, non-sterile device.

    These gloves were tested for use with chemotherapy drugs per ASTM D6978-05 (2019)Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. Tested chemotherapy drugs are as follows: Carboplatin, 10 mg/ml >240 min. Carmustine (BCNU), 3.3 mg/ml 27.5 min Cisplatin, 1.0 mg/ml >240 min Cyclophosphamide (Cytoxan), 20.0 mg/ml >240 min Doxorubicin HCI, 2.0 mg/ml >240 min Etoposide, 20.0 mg/ml >240 min Fluorouracil, 50.0 mg/ml >240 min Paclitaxel, 6.0 mg/ml >240 min Thio Tepa, 10.0 mg/ml 88.2 min

    Please note that the following drugs have low permeation times: Carmustine (BCNU) 3.3 mg/ml 27.5 Minutes, Thio Tepa 10.0 mg/ml 88.2 Minutes.

    Warning: Please do not use with Carmustine and Thio Tepa.

    Device Description

    The proposed device (Mode: NG101) is powder free nitrile examination gloves, provided as non-sterile and disposable device. The proposed devices are blue color and there are five sizes, include XS (6.5"), S (7"), M (8"), L (8.5"), XL (9") for optional. The examination glove is smooth surface with textured fingertips and a rolled rim at the cuff edge. This is a single-use, powder-free, non-sterile device.

    The gloves are designed and manufactured in accordance with the ASTM D6319-10 standard and are tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019)

    AI/ML Overview

    The document describes the non-clinical testing performed to demonstrate that the Nitrile Patient Examination Gloves (K221747) meet their acceptance criteria and are substantially equivalent to a predicate device (K211220).

    1. Table of Acceptance Criteria and Reported Device Performance:

    Test MethodologyPurposeAcceptance CriteriaReported Device Performance
    ASTM D6319-19Physical DimensionThe actual measured dimension of the gloves shall meet the stated tolerance specified in Table 2 of ASTM D6319-19.Meet the requirement
    ASTM D6319-19Determination of Physical PropertiesBefore and after accelerated aging, the gloves shall conform to the physical requirements in Table 3 of ASTM 6319-19 (Tensile Strength: Before Aging ≥ 14 MPa, After Aging ≥ 14 MPa. Elongation: Before Aging 500%, After Aging 400%).Meet the requirement
    ASTM D5151-19Water Leak Test for Detection of HolesThe gloves shall be free from hole when tested in accordance with the method given in ASTM D5151-19, AQL = 2.5.Meet the requirement
    ASTM D6124-06(2017)Residual Powder Content TestThe powder residue content shall be not more than 2mg per glove.Meet the requirement
    ISO 10993-5: 2009In Vitro CytotoxicityThe MEM test extract shows no cytotoxic potential to L929 mouse fibroblast cells.Meet the requirement
    ISO 10993-10: 2010Skin SensitizationThe test article extracts show no evidence of causing delayed dermal contact sensitization in the guinea pig.Meet the requirement
    ISO 10993-10: 2010Skin IrritationThere is no erythema and no edema observed on the skin of the animals treated with the test extracts.Meet the requirement
    ASTM D6978-05 (Chemotherapy Drugs)Chemotherapy Drugs (Permeation Breakthrough Time)Carboplatin, 10 mg/ml >240 min.Carmustine (BCNU), 3.3 mg/ml 27.5 minCisplatin, 1.0 mg/ml >240 minCyclophosphamide (Cytoxan), 20.0 mg/ml >240 minDoxorubicin HCl, 2.0 mg/ml >240 minEtoposide, 20.0 mg/ml >240 minFluorouracil, 50.0 mg/ml >240 minPaclitaxel, 6.0 mg/ml >240 minThio Tepa, 10.0 mg/ml 88.2 minExcept for Carmustine and Thio Tepa, acceptance criteria were met.

    2. Sample size used for the test set and the data provenance:

    The document does not explicitly state the sample sizes for each specific test within the non-clinical testing. It generally refers to "Final finished product" as the tested sample. The data provenance is not specified, but it can be inferred that the testing was conducted by or on behalf of the manufacturer, Fitone Latex Products Co., Ltd. Guangdong, which is based in China. The nature of the tests (physical, chemical, and biocompatibility) suggests these were laboratory-based tests on manufactured product samples. The document does not indicate if the data is retrospective or prospective, though it is standard practice for such tests to be prospective assessments of newly manufactured products.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    This information is not applicable as the tests described are non-clinical, objective measurements against established ASTM and ISO standards for material properties and performance. There is no human interpretation or expert ground truth establishment for these types of tests (e.g., measuring glove dimensions, tensile strength, or chemical permeation).

    4. Adjudication method for the test set:

    This information is not applicable for the same reason as point 3. Adjudication methods are typically used in studies involving human interpretation or subjective assessments.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    This information is not applicable. The submission is for a medical glove, not an AI-powered diagnostic device. Therefore, no MRMC study or AI assistance comparison was conducted.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

    This information is not applicable as the device is not an algorithm or AI-based system.

    7. The type of ground truth used:

    The "ground truth" for the non-clinical tests is based on established industry standards and specifications:

    • ASTM D6319-19 (Standard Specification for Nitrile Examination Gloves for Medical Application)
    • ASTM D5151-19 (Test Method for Detection of Holes in Medical Gloves)
    • ASTM D6124-06(2017) (Test Method for Residual Powder on Medical Gloves)
    • ASTM D573-04(2019) (Test Method for Rubber-Deterioration in an Air Oven)
    • ISO 10993-5: 2009 (Biological Evaluation Of Medical Devices -- Part 5: Tests For In Vitro Cytotoxicity)
    • ISO 10993-10: 2010 (Biological Evaluation Of Medical Devices Part 10: Tests For Irritation And Skin Sensitization)
    • ASTM D6978-05 (Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs)

    These standards define the acceptance criteria (e.g., minimum tensile strength, maximum residual powder, breakthrough times for chemotherapy drugs).

    8. The sample size for the training set:

    This information is not applicable as there is no training set for a medical glove. These are physical products tested against predetermined specifications.

    9. How the ground truth for the training set was established:

    This information is not applicable as there is no training set.

    Ask a Question

    Ask a specific question about this device

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The nitrile examination glove is intended to be worn on the hands of examination between patient and examiner. This is a single-use, powder-free, non-sterile device.

    The Nitrile Patient Examination Gloves Blue Colored were tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. The tested chemotherapy drug are as follows:

    Bleomycin Sulfate 15 mg/ml >240 min. Busulfan 6 mg/ml >240 min. Carboplatin 10 mg/ml >240 min. Carmustine (BCNU) 3.3 mg/ml 17.2 min. Cisplatin 1.0 mg/ml >240 min. Cyclophosphamide (Cytoxan) 20.0 mg/ml >240 min. Cytarabine HCI 100 mg/ml >240 min. Dacarbazine (DTIC)10.0 mg/ml >240 min. Daunorubicin 5 mg/mL >240 min. Docetaxel 10.0 mg/ml >240 min Doxorubicin HCI 2.0 mg/ml >240 min. Epirubicin HCI 2.0 mg/ml >240 min. Etoposide (Toposar) 20.0 mg/ml >240 min. Fludarabine 25.0 mg/ml >240 min. Fluorouracil 50.0 mg/ml >240 min. Gemcitabine 38 mg/ml>240 min. Idarubicin 1 mg/ml >240 min. Ifosfamide 50.0 mg/ml >240 min. Irinotecan 20.0 mg/ml >240 min. Mechlorethamine HCI 1.0 mg/ml>240 min. Melphalan 5 mg/ml >240 min. Methotrexate 25 mg/ml >240 min. Mitromvcin C. 0.5 mg/ml >240 Mitoxantrone 2.0 mg/ml >240 min. Paclitaxel (Taxol) 6.0 mg/ml >240 min. Rituximab 10.0 mg/ml >240 min. Thiotepa 10.0 mg/ml 13.9min. Trisenox 1.0 mg/ml >240 min. Vincristine Sulfate 1.0 mg/ml >240 min. Fentanyl Citrate 100mcg/2ml >240 minutes

    Warning: Do not use with Carmustine and Thiotepa.

    The Nitrile Patient Examination Gloves Blue Violet Colored were tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    The tested chemotherapy drug are as follows: Bleomycin Sulfate 15 mg/ml >240 min. Busulfan 6 mg/ml >240 min. Carboplatin 10 mg/ml >240 min. Carmustine (BCNU) 3.3 mg/ml 65.3 min. Cisplatin 1.0 mg/ml >240 min. Cyclophosphamide (Cytoxan) 20.0 mg/ml >240 min. Cytarabine HCI 100 mg/ml >240 min. Dacarbazine (DTIC)10.0 mg/ml >240 min. Daunorubicin 5 mg/mL >240 min. Docetaxel 10.0 mg/ml >240 min Doxorubicin HCI 2.0 mg/ml >240 min. Epirubicin HCl 2.0 mg/ml >240 min. Etoposide (Toposar) 20.0 mg/ml >240 min. Fludarabine 25.0 mg/ml >240 min. Fluorouracil 50.0 mg/ml >240 min. Gemcitabine 38 mg/ml>240 min. Idarubicin 1 mg/ml >240 min. Ifosfamide 50.0 mg/ml >240 min. Irinotecan 20.0 mg/ml >240 min. Mechlorethamine HCI 1.0 mg/ml>240 min. Melphalan 5 mg/ml >240 min. Methotrexate 25 mg/ml >240 min. Mitromvcin C. 0.5 mg/ml >240 Mitoxantrone 2.0 mg/ml >240 min. Paclitaxel (Taxol) 6.0 mg/ml >240 min. Rituximab 10.0 mg/ml >240 min. Thiotepa 10.0 mg/ml 58.3min. Trisenox 1.0 mg/ml >240 min. Vincristine Sulfate 1.0 mg/ml >240 min. Fentanyl Citrate 100mcg/2ml >240 minutes

    Warning: Do not use with Carmustine and Thiotepa.

    The Nitrile Patient Examination Gloves Black Colored were tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

    The tested chemotherapy drug are as follows: Carmustine (BCNU) 3.3 mg/ml 49.2 min. Cisplatin 1.0 mq/ml >240 min. Cyclophosphamide (Cytoxan) 20.0 mg/ml >240 min. Dacarbazine (DTIC)10.0 mg/ml >240 min. Doxorubicin HCI 2.0 mg/ml >240 min. Etoposide (Toposar) 20.0 mg/ml >240 min. Fluorouracil 50.0 mg/ml >240 min. Fentanyl Citrate 100mcg/2ml >240 minutes Paclitaxel (Taxol) 6.0 mg/ml >240 min. Thiotepa 10.0 mg/ml 87.1min.

    Warning: Do not use with Carmustine and Thiotepa.

    Device Description

    Powder-Free Nitrile Examination Gloves (Tested for Use with Chemotherapy Drugs) are non-sterile, single use, disposable gloves intended for medical purposes to be worn on the hands of examiners to prevent contamination between a patient and an examiner. The gloves are offered in six sizes, extra-small, medium, large, extralarge, extra-extra-large. Three colors are available for all size, includes blue, blue violet and black.

    The gloves are designed and manufactured in accordance with the ASTM D6319-10 standard and are tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019).

    AI/ML Overview

    This document describes the premarket notification (510(k)) for Nitrile Patient Examination Gloves, with specific testing for chemotherapy drug permeation. Based on the provided text, the "device" is a physical product (gloves) and not an AI/software device, therefore many of the requested criteria (MRMC study, AI assistance, ground truth establishment, training set, etc.) are not applicable.

    Here's the breakdown of the acceptance criteria and the study proving the device meets them, based entirely on the provided text:


    Acceptance Criteria and Reported Device Performance

    1. Table of Acceptance Criteria and Reported Device Performance:

    Test MethodologyPurposeAcceptance CriteriaResults
    ASTM D6319 (Physical Dimensions)Physical Dimensions TestLength:Extra-Small: ≥ 220mmSmall: ≥ 220mmMedium: ≥ 230mmLarge: ≥ 230mmExtra-Large: ≥ 230mmExtra-Extra-Large: ≥ 230mmWidth:Extra-Small: 70±10mmSmall: 80±10mmMedium: 95±10mmLarge: 110±10mmExtra-Large: 120±10mmExtra-Extra-Large: ≥120mmThickness (mm):Finger: ≥0.05Palm: ≥0.08Pass
    ASTM D6319 (Physical Properties)Physical Properties (Tensile Strength & Elongation)Before Aging:Tensile Strength: ≥14MPaUltimate Elongation: ≥500%After Aging:Tensile Strength: ≥14MPaUltimate Elongation: ≥500%Pass
    ASTM D5151Freedom from pinholesMeet the requirements of ASTM D5151 Test for AQL 2.5Pass
    ASTM D6124Powder ResidueMeet the requirements of ASTM D6124 < 2.0mgPass
    ISO 10993-10To determine if the finished device material is an irritantNon-irritatingUnder the conditions of the study, not an irritant/ Pass
    ISO 10993-10To determine if the finished device material is a sensitizerNon-sensitizingUnder conditions of the study, not a sensitizer. / Pass
    ISO 10993-11To determine if the finished device material extracts pose a systemic toxicity concernNon-acute systemic toxicityUnder conditions of the study, did not show acute systemic toxicity in vivo / Pass
    ASTM D6978-05 (Reapproved 2019)Assessment of Medical Gloves to Permeation by Chemotherapy Drugs and Fentanyl CitrateNitrile Patient Examination Gloves Blue (Tested Drugs & Permeation Time):- Bleomycin Sulfate 15 mg/ml: >240 min.- Busulfan 6 mg/ml: >240 min.- Carboplatin 10 mg/ml: >240 min.- Carmustine (BCNU) 3.3 mg/ml: 17.2 min.- Cisplatin 1.0 mg/ml: >240 min.- Cyclophosphamide (Cytoxan) 20.0 mg/ml: >240 min.- Cytarabine HCI 100 mg/ml: >240 min.- Dacarbazine (DTIC)10.0 mg/ml: >240 min.- Daunorubicin 5 mg/mL: >240 min.- Docetaxel 10.0 mg/ml: >240 min- Doxorubicin HCI 2.0 mg/ml: >240 min.- Epirubicin HCI 2.0 mg/ml: >240 min.- Etoposide (Toposar) 20.0 mg/ml: >240 min.- Fludarabine 25.0 mg/ml: >240 min.- Fluorouracil 50.0 mg/ml: >240 min.- Gemcitabine 38 mg/ml: >240 min.- Idarubicin 1 mg/ml: >240 min.- Ifosfamide 50.0 mg/ml: >240 min.- Irinotecan 20.0 mg/ml: >240 min.- Mechlorethamine HCI 1.0 mg/ml: >240 min.- Melphalan 5 mg/ml: >240 min.- Methotrexate 25 mg/ml: >240 min.- Mitomycin C. 0.5 mg/ml: >240- Mitoxantrone 2.0 mg/ml: >240 min.- Paclitaxel (Taxol) 6.0 mg/ml: >240 min.- Rituximab 10.0 mg/ml: >240 min.- Thiotepa 10.0 mg/ml: 13.9 min.- Trisenox 1.0 mg/ml: >240 min.- Vincristine Sulfate 1.0 mg/ml: >240 min.- Fentanyl Citrate 100mcg/2ml: >240 minutesWarning: Do not use with Carmustine and Thiotepa.Nitrile Patient Examination Gloves Blue Violet (Tested Drugs & Permeation Time):- Bleomycin Sulfate 15 mg/ml: >240 min.- Busulfan 6 mg/ml: >240 min.- Carboplatin 10 mg/ml: >240 min.- Carmustine (BCNU) 3.3 mg/ml: 65.3 min.- Cisplatin 1.0 mg/ml: >240 min.- Cyclophosphamide (Cytoxan) 20.0 mg/ml: >240 min.- Cytarabine HCI 100 mg/ml: >240 min.- Dacarbazine (DTIC)10.0 mg/ml: >240 min.- Daunorubicin 5 mg/mL: >240 min.- Docetaxel 10.0 mg/ml: >240 min- Doxorubicin HCI 2.0 mg/ml: >240 min.- Epirubicin HCl 2.0 mg/ml: >240 min.- Etoposide (Toposar) 20.0 mg/ml: >240 min.- Fludarabine 25.0 mg/ml: >240 min.- Fluorouracil 50.0 mg/ml: >240 min.- Gemcitabine 38 mg/ml: >240 min.- Idarubicin 1 mg/ml: >240 min.- Ifosfamide 50.0 mg/ml: >240 min.- Irinotecan 20.0 mg/ml: >240 min.- Mechlorethamine HCI 1.0 mg/ml: >240 min.- Melphalan 5 mg/ml: >240 min.- Methotrexate 25 mg/ml: >240 min.- Mitomycin C. 0.5 mg/ml: >240- Mitoxantrone 2.0 mg/ml: >240 min.- Paclitaxel (Taxol) 6.0 mg/ml: >240 min.- Rituximab 10.0 mg/ml: >240 min.- Thiotepa 10.0 mg/ml: 58.3 min.- Trisenox 1.0 mg/ml: >240 min.- Vincristine Sulfate 1.0 mg/ml: >240 min.- Fentanyl Citrate 100mcg/2ml: >240 minutesWarning: Do not use with Carmustine and Thiotepa.Nitrile Patient Examination Gloves Black (Tested Drugs & Permeation Time):- Carmustine (BCNU) 3.3 mg/ml: 49.2 min.- Cisplatin 1.0 mg/ml: >240 min.- Cyclophosphamide (Cytoxan) 20.0 mg/ml: >240 min.- Dacarbazine (DTIC)10.0 mg/ml: >240 min.- Doxorubicin HCI 2.0 mg/ml: >240 min.- Etoposide (Toposar) 20.0 mg/ml: >240 min.- Fluorouracil 50.0 mg/ml: >240 min.- Fentanyl Citrate 100mcg/2ml: >240 minutes- Paclitaxel (Taxol) 6.0 mg/ml: >240 min.- Thiotepa 10.0 mg/ml: 87.1 min.Warning: Do not use with Carmustine and Thiotepa.The permeation resistance was tested and the break-through times for each listed chemotherapy drug are reported as the "Results" for each glove colored variation. The tables within the document (pages 8-10, and 12-14) explicitly list these times. The general acceptance criterion for these types of tests is generally that the glove provides a minimum specified protection time (e.g., >240 minutes for many drugs, unless a shorter warning is given), and these results are directly reported. The "Pass" in the summary table (page 18) indicates overall compliance with the standard for specific tests.

    2. Sample size used for the test set and the data provenance:

    • Sample Size: The document does not specify the exact sample size (number of gloves) used for each individual test (e.g., how many gloves were tested for permeation by each drug). It generally refers to "tests" being performed.
    • Data Provenance: The tests were conducted according to established ASTM and ISO standards for medical devices. The manufacturer is "Guang Dong Kingfa Sci. & Tech.Co., Ltd." in China. The data itself is from laboratory testing, not from patient data. The studies are non-clinical (in-vitro, physical/chemical tests).

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • Not Applicable. This is a physical device (medical gloves) and not an AI/software device that requires expert human interpretation or consensus for ground truth establishment. The "ground truth" here is the measured performance of the glove against established physical and chemical standards (e.g., tensile strength, pinhole presence, chemical permeation time).

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

    • Not Applicable. As this is not an AI/software device involving human-in-the-loop decisions or human interpretive tasks, no adjudication method for ground truth was used.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • Not Applicable. This is a physical device, not an AI/software system for medical image analysis or diagnosis.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

    • Not Applicable. This is a physical device, not an algorithm. The device's performance is standalone in that its properties (e.g., permeation resistance) are directly measured.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

    • The "ground truth" for these tests is defined by adherence to published international standards (ASTM D6319, ASTM D5151, ASTM D6124, ISO 10993-10, ISO 10993-11, and particularly ASTM D6978-05 for chemotherapy drug permeation). For the chemotherapy drug permeation specifically, the ground truth is the experimentally determined breakthrough time of the specific chemicals through the glove material under controlled laboratory conditions, as specified by the standard.

    8. The sample size for the training set:

    • Not Applicable. This is a physical device; there is no 'training set' in the machine learning sense. The manufacturing process and quality control would involve internal testing, but this is not referred to as a "training set" in the context of typical AI/ML device submissions.

    9. How the ground truth for the training set was established:

    • Not Applicable. As there is no training set for an AI/ML model, this point does not apply.
    Ask a Question

    Ask a specific question about this device

    K Number
    K220697
    Date Cleared
    2022-09-15

    (190 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Nitrile Patient Examination Gloves, Powder Free, are intended for medical purposes that are worn on the examiners' hands to prevent contamination between patient and examiner.

    Device Description

    The Nitrile Patient Examination Gloves, Powder Free are non-sterile, single use only, disposable, and powder free examination gloves. The glove is made of synthetic nitrile latex compound. The device is ambidextrous and can be worn on either the left or right hand. The device meets ASTM D 6319 - Standard specification for Nitrile Examination Gloves for Medical Application.

    AI/ML Overview

    This document is a 510(k) Premarket Notification for Nitrile Patient Examination Gloves, Powder Free. It demonstrates the substantial equivalence of the proposed device to a legally marketed predicate device (Primus Nitrile Examination Gloves, K143477).

    Here's the breakdown of the acceptance criteria and study information:

    1. Table of Acceptance Criteria and Reported Device Performance

    Device: Nitrile Patient Examination Gloves, Powder Free (Lalan Rubbers (Pvt) Ltd)

    CharacteristicAcceptance Criteria (Predicate Device / ASTM D6319)Reported Device Performance (Nitrile Patient Examination Gloves, Powder Free)
    Physical Characteristics:ASTM D6319 requirementsMeets ASTM D6319 requirements
    LengthMinimum 230mmMinimum 240mm
    Palm width (XS)$70 \pm 10$$\leq 80$
    Palm width (S)$80 \pm 10$$85 \pm 5$
    Palm width (M)$95 \pm 10$$95 \pm 5$
    Palm width (L)$110 \pm 10$$105 \pm 5$
    Palm width (XL)$120 \pm 10$$\geq 110$
    Thickness (Finger)Minimum 0.05mm$0.09 \pm 0.01$mm
    Thickness (Palm)Minimum 0.05mm$0.07 \pm 0.01$mm
    Thickness (Cuff)Not explicitly defined (implied by ASTM)$0.05 \pm 0.01$mm
    Physical Properties:ASTM D6319 requirements for tensile strength and ultimate elongationMeets ASTM D6319 requirements
    Tensile Strength (Before Aging)Minimum 14 MPaMinimum 14 MPa
    Tensile Strength (After Aging)Minimum 14 MPaMinimum 14 MPa
    Ultimate Elongation (Before Aging)Minimum 500%Minimum 500%
    Ultimate Elongation (After Aging)Minimum 400%Minimum 400%
    Freedom from holes:ASTM D6319 requirements of GI, AQL 2.5Meets ASTM D6319 and ASTM D5151 requirements of AQL 2.5
    Powder Residual:ASTM D6319 requirements; Not more than 2.0mg/gloveMeets applicable requirement for powder free; $\leq$ 2 mg per glove
    Biocompatibility:ASTM and ISO standards-
    Skin Irritation TestNot an irritant (Under predicate study conditions)Under the conditions of the study, not an irritant (ISO10993-23:2021)
    Skin Sensitization TestNot a sensitizer (Under predicate study conditions)Under the conditions of the study, not a sensitizer (ISO 10993-10:2010)
    In Vitro CytotoxicityNot explicitly stated for predicateDiluted concentrations 12.5% and 6.25% are not cytotoxic. Undiluted extract (100%), diluted concentrations 50% & 25% are cytotoxic. (ISO 10993-5:2009)
    Acute Systemic ToxicityNot explicitly stated for predicateUnder the conditions of the study, no evidence of systemic toxicity (ISO 10993-11: 2017)
    Shelf Life3 years3 years (EN, 455-4:2009)

    2. Sample size used for the test set and the data provenance

    The document specifies that non-clinical tests were conducted to verify that the proposed subject device met all design specifications. The sample sizes for each specific test (e.g., number of gloves for physical testing, number of samples for biocompatibility) are not explicitly provided in this summary document. However, the tests are performed according to recognized international standards (ASTM and ISO), which typically specify appropriate sample sizes and methodologies.

    The "data provenance" (country of origin, retrospective/prospective) is not detailed for the test samples, but the tests were performed by Lalan Rubbers (Pvt) Ltd in Sri Lanka, which is the manufacturer. The tests are prospective in nature, as they involve testing newly manufactured devices against established standards.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This device (Nitrile Patient Examination Gloves) does not involve expert interpretation or clinical diagnosis that would require human "ground truth" establishment in the typical sense of AI/clinical decision support systems. The "ground truth" here is objective measurement against established physical and chemical standards (ASTM D6319, ISO 10993 series). Therefore, there were no "experts" establishing a subjective ground truth for a test set in this context. The acceptance criteria are quantitative and based on published standards.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Not applicable. As noted above, the "ground truth" is objective measurement against established physical and chemical standards. There is no subjective interpretation requiring adjudication.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This device is a medical glove, not an AI-assisted diagnostic or clinical decision support system that involves human readers interpreting cases.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This is not an algorithm or AI device. The tests performed are for the physical, chemical, and biological properties of the glove itself.

    7. The type of ground truth used

    The ground truth used for this device's performance evaluation against acceptance criteria is objective measurement against recognized international standards and specifications. Specifically:

    • Physical and Dimensional Properties: ASTM D6319 (Standard Specification for Nitrile Examination Gloves for Medical Application)
    • Freedom from holes: ASTM D6319 and ASTM D5151 (Standard Test Method for Detection of Holes in Medical Gloves)
    • Powder Residual: ASTM D6319 and ASTM D6124 (Standard Test Method for Residual Powder on Medical Gloves)
    • Biocompatibility: ISO 10993-10, ISO 10993-23, ISO 10993-11, ISO 10993-5 (Biological evaluation of medical devices for irritation, sensitization, systemic toxicity, and cytotoxicity)
    • Shelf Life: EN 455-4:2009 (Medical gloves for single use Part 4: Requirements and testing for shelf life determination)

    8. The sample size for the training set

    Not applicable. This product is not an AI/machine learning model, so there is no concept of a "training set" in this context. The design and manufacturing process for the gloves are developed based on general engineering and material science principles, and then verified through the non-clinical tests mentioned.

    9. How the ground truth for the training set was established

    Not applicable, as there is no training set for this device.

    Ask a Question

    Ask a specific question about this device

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The blue colored nitrile examination glove is intended to be worn on the hands of examiner's to prevent contamination between patient and examiner. This is a single-use, powder-free, non-sterile device. The Nitrile Patient Examination Gloves Blue Colored were tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. The tested chemotherapy drug are as follows: Bleomycin Sulfate 15 mg/ml >240 min., Carboplatin 10 mg/ml >240 min., Carmustine (BCNU) 3.3 mg/ml 17.2 min., Cisplatin 1.0 mg/ml >240 min., Cyclophosphamide (Cytoxan) 20.0 mg/ml >240 min., Cytarabine HCI 100 mg/ml >240 min., Dacarbazine (DTIC)10.0 mg/ml >240 min., Daunorubicin 5.0 mg/ml >240 min., Docetaxel 10.0 mg/ml >240 min, Doxorubicin HCI 2.0 mg/ml >240 min., Etoposide (Toposar) 20.0 mg/ml >240 min., Fluorouracil 50.0 mg/ml >240 min., Gemcitabine 38 mg/ml>240 min., Idarubicin 1 mg/ml >240 min., Ifosfamide 50.0 mg/ml >240 min., Irinotecan 20.0 mg/ml >240 min., Mechlorethamine HCI 1.0 mg/ml>240 min., Melphalan 5 mg/ml >240 min., Methotrexate 25 mg/ml >240 min., Mitromycin C. 0.5 mg/ml >240, Mitoxantrone 2.0 mg/ml >240 min., Paclitaxel (Taxol) 6.0 mg/ml >240 min., Thiotepa 10.0 mg/ml 13.9 min., Vincristine Sulfate 1.0 mg/ml >240 min. Warning: Do not use with Carmustine and Thiotepa.

    The nitrile examination glove is intended to be worn on the hands of examination between patient and examiner. This is a single-use, powder-free, non-sterile device. The Nitrile Patient Examination Gloves Blue Violet Colored were tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. The tested chemotherapy drug are as follows: Carmustine (BCNU) 3.3 mg/ml 65.3 min., Cisplatin 1.0 mg/ml >240 min., Cyclophosphamide (Cytoxan) 20.0 mg/ml >240 min., Dacarbazine (DTIC)10.0 mg/ml >240 min., Doxorubicin HCI 2.0 mg/ml >240 min., Etoposide (Toposar) 20.0 mg/ml >240 min., Fluorouracil 50.0 mg/ml >240 min., Methotrexate 25 mg/ml >240 min., Paclitaxel (Taxol) 6.0 mg/ml >240 min., Thiotepa 10.0 mg/ml 58.3 min. Warning: Do not use with Carmustine and Thiotepa.

    The nitrile examination glove is intended to be worn on the hands of examination between patient and examiner. This is a single-use, powder-free, non-sterile device. The Nitrile Patient Examination Gloves Black Colored were tested for use with Fentanyl Citrate per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. Fentanyl Citrate 100mcg/2ml >240 minutes.

    Device Description

    Power-Free Nitrile Examination Gloves (Tested for Use with Chemotherapy Drugs) are non-sterile, single use, disposable gloves intended for medical purposes to be worn on the hands of examiners to prevent contamination between a patient and an examiner. The gloves are offered in six sizes, x-small (6.5"), small (7"), medium (8"), large (8.5"), X-large (9"), XXL (9.5"). Three colors are available for all size, includes blue, blue violet and black. The gloves are designed and manufactured in accordance with the ASTM D6319-19 standard and are tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019).

    AI/ML Overview

    The provided document describes the acceptance criteria and study results for "Nitrile Patient Examination Gloves" (various colors) tested for use with chemotherapy drugs or Fentanyl Citrate. This is a medical device, and the evaluation is based on non-clinical performance standards rather than an AI/ML algorithm.

    Therefore, many of the requested fields related to AI/ML studies (sample size for test set, data provenance, number of experts, adjudication method, MRMC comparative effectiveness, standalone performance, ground truth for training set, training set size) are not applicable to this submission.

    Here's the breakdown of the available information:

    1. Table of Acceptance Criteria and Reported Device Performance

    Test ItemMethodology / StandardAcceptance CriteriaReported Device Performance
    Physical Dimensions
    Palm widthASTM D3767-03(2020)XS (70±10mm)S (80±10mm)M (95±10mm)L (110±10mm)XL (120±10mm)XXL (≥ 120mm)Pass
    LengthASTM D3767-03(2020)XS (220mm min)S (220mm min)M (230mm min)L (230mm min)XL (230mm min)XXL (230mm min)Pass
    ThicknessASTM D3767-03(2020)Finger: 0.11mmPalm: 0.05mmPass
    Integrity
    Freedom from holesASTM D5151-19Freedom free holeAQL 2.5Pass
    Physical Properties (before aging)
    Tensile StrengthASTM D412-16≥ 14MpaPass
    Ultimate ElongationASTM D412-16≥ 500%Pass
    Physical Properties (after aging)
    Tensile StrengthASTM D573-04(2019)≥ 14MpaPass
    Ultimate ElongationASTM D573-04(2019)≥ 400%Pass
    Chemical Content
    Residual Powder ContentASTM D6124-06(2017)≤2mg per glovePass
    Biocompatibility
    CytotoxicityISO 10993-5Non-cytotoxicUnder conditions of the study, device extract is cytotoxic.
    Acute Systemic ToxicityISO 10993-11Non-acute systemic toxicityUnder conditions of the study, did not show acute systemic toxicity in vivo / Pass
    IrritationISO 10993-10Non-irritatingUnder the conditions of the study, not an irritant/ Pass
    SensitizationISO 10993-10Non-sensitizingUnder conditions of the study, not a sensitizer./ Pass
    Chemotherapy Drug PermeationASTM D6978-05 (Reapproved 2019)Min. permeation breakthrough time as specified for each drugAchieved or exceeded specified times for individual drugs (see detailed lists in pages 2, 4, 5, 7, 8, 11, 12).
    Fentanyl Citrate PermeationASTM D6978-05 (Reapproved 2019)Min. permeation breakthrough time as specified (e.g., >240 min)Achieved >240 minutes for Fentanyl Citrate (see detailed lists in pages 5, 8, 12).

    2. Sample size used for the test set and the data provenance

    • Sample Size: Not explicitly stated for each test, but standard ASTM and ISO methods generally specify sample sizes. For example, AQL 2.5 for "freedom from holes" implies a sampling plan. Since these are performance tests on manufactured goods, the "test set" would be a batch or set of gloves sampled from production.
    • Data Provenance: The document does not specify a country of origin for the testing data. The studies are described as "Non clinical tests" performed according to established international standards (ASTM, ISO). They are prospective in the sense that they are performed on the device to be marketed.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    • This is not applicable as the "ground truth" for these tests is defined by objective physical and chemical measurements according to standardized protocols (ASTM, ISO), not expert interpretation.

    4. Adjudication method for the test set

    • Not applicable, as the evaluation is based on objective measurements against defined standards.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • Not applicable. This is a submission for physical medical gloves, not an AI/ML-driven device.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

    • Not applicable. This is a submission for physical medical gloves, not an AI/ML-driven device.

    7. The type of ground truth used

    • The "ground truth" for these tests is the direct measurement of physical properties (e.g., dimensions, tensile strength, elongation), chemical properties (e.g., residual powder content), and barrier properties (permeation breakthrough time for chemotherapy drugs and Fentanyl Citrate) against established, objective industry standards (ASTM, ISO). For biocompatibility, it's the observed biological response to the glove material under controlled test conditions.

    8. The sample size for the training set

    • Not applicable. This is a submission for physical medical gloves, not an AI/ML-driven device.

    9. How the ground truth for the training set was established

    • Not applicable. This is a submission for physical medical gloves, not an AI/ML-driven device.
    Ask a Question

    Ask a specific question about this device

    K Number
    K213048
    Date Cleared
    2021-12-18

    (87 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination gloves is a disposable device intended for medical purpose that is worn on the examiner's hand or fingers to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978-05 Standard Practice for Assessment of Medical gloves to Permeation by Chemotherapy Drugs.

    Device Description

    The subject device is single use, disposable gloves intended for medical purposes to be worn on the examiner's hands to prevent contamination between patient and examiner. The gloves are powder-free, ambidextrous with beaded cuff, blue colored, nitrile, and tested for use with chemotherapy drugs. The gloves are offered in six sizes: XS, S, M, L, XL, XXL. The subject device is non-sterile.

    AI/ML Overview

    This document describes the safety and performance of Nitrile Patient Examination Gloves (Tested for Use with Chemotherapy Drugs) as submitted for FDA 510(k) clearance (K213048). The study focuses exclusively on comprehensive bench testing and biocompatibility assessments, demonstrating the device's adherence to established standards for medical gloves, particularly regarding chemotherapy drug permeation.

    1. Table of Acceptance Criteria and Reported Device Performance

    Test MethodPurposeAcceptance CriteriaReported Device Performance
    ASTM D6319Physical Dimensions TestLength (mm):XS: ≥220;S/M/L/XL/XXL: ≥230Width (mm):XS: 70±10;S: 80±10;M: 95±10;L: 110±10;XL: 120±10;XXL: 130±10Thickness (mm):Finger: ≥0.05;Palm: ≥0.05Length (mm):All sizes: > 240/PassWidth (mm):XS: 80-83/PassS: 86-90/PassM: 97-98/PassL: 108-112/PassXL: 115-120/PassXXL: 128-130/PassThickness (mm):Finger: 0.08-0.10/PassPalm: 0.08-0.11/Pass
    ASTM D5151Watertightness Test for Detection of HolesMeet the requirements of ASTM D5151 AQL 2.50/125/Pass (This implies that out of 125 samples tested, 0 failed, meeting AQL 2.5)
    ASTM D6124Powder ContentMeet the requirements of ASTM D6124 < 2.0mg0.03mg/Pass
    ASTM D412Physical properties (Before Aging)Tensile Strength: ≥14MPaUltimate Elongation: ≥500%Tensile Strength: 15.1-16.9MPa/PassUltimate Elongation: 536-559%/Pass
    ASTM D412Physical properties (After Aging)Tensile Strength: ≥14MPaUltimate Elongation: ≥400%Tensile Strength: 16.0-18.0MPa/PassUltimate Elongation: 540-553%/Pass
    ISO 10993-5CytotoxicityNon- In Vitro CytotoxicityUnder conditions of the study, device extract is not cytotoxic. /Pass
    ISO 10993-10IrritationNon-irritatingUnder the conditions of the study, not an irritant. / Pass
    ISO 10993-10SensitizationNon-sensitizingUnder conditions of the study, not a sensitizer. / Pass
    ASTM D6978-05 (Chemotherapy Drug Permeation)Assessment of Resistance to Permeation by Chemotherapy DrugsBreakthrough Detection Time for specific drugs to meet or exceed established benchmarks. The established benchmark is typically >240 minutes for many drugs, but lower times are accepted for certain highly permeable drugs, provided they are clearly labeled with warnings.Carboplatin: > 240 MinutesCarmustine (BCNU): 26.5 Minutes (Warning advised)Cyclophosphamide: > 240 MinutesDoxorubicin: > 240 MinutesEtoposide: > 240 MinutesFluorouracil: > 240 MinutesMethotrexate: > 240 MinutesPaclitaxel: > 240 MinutesThioTepa: 48.4 Minutes (Warning advised)

    2. Sample Sizes Used for the Test Set and Data Provenance

    The document does not explicitly state the specific number of units (gloves) for each test, but it does refer to meeting ASTM standards, which would imply a scientifically sound sampling methodology.
    For the Watertightness Test, the results state "0/125/Pass," indicating a sample size of 125 units was tested for holes.
    The data provenance is based on non-clinical laboratory testing (bench testing) performed by or for Huayuan Medical Technology (Shangqiu) Co., Ltd. The specific location of testing is not detailed beyond the company's address in Shangqiu City, Henan Province, China. The data would be considered prospective for the purposes of this 510(k) submission, as these tests were conducted to demonstrate compliance for the specific device.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    Not applicable. This submission relies on objective, standardized bench tests (e.g., ASTM, ISO standards) to establish performance. The "ground truth" is defined by the technical specifications and criteria outlined in these industry-recognized standards, rather than expert consensus on subjective data (like image interpretation in AI/clinical studies). No human experts were used to establish ground truth in the context of clinical/radiological assessment. The experts involved would be laboratory technicians and engineers qualified to perform and interpret the specified physical, chemical, and biological tests according to the standards.

    4. Adjudication Method for the Test Set

    Not applicable. Since the study involves objective bench testing against pre-defined acceptance criteria from international standards (ASTM, ISO), no human adjudication of test results is typically required beyond standard quality control and verification procedures of the testing laboratory.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done

    No. This K213048 submission is for Nitrile Patient Examination Gloves, which are a physical medical device, not a diagnostic imaging AI system. Therefore, an MRMC comparative effectiveness study, which is relevant for evaluating the impact of AI on human reader performance in diagnostic tasks, was not performed. The study focuses on the physical and chemical properties of the gloves.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Study was done

    Not applicable. This is not an AI-powered diagnostic device or software. The "performance" being assessed is the physical and chemical resistance of the gloves, which is inherently a standalone performance of the material and manufacturing process under controlled laboratory conditions.

    7. The Type of Ground Truth Used

    The "ground truth" for this device is established by objective laboratory measurements against pre-defined technical specifications and performance criteria set forth in internationally recognized standards (ASTM D6319, ASTM D5151, ASTM D6124, ASTM D412, ASTM D6978-05, ISO 10993-5, ISO 10993-10). For example, the ground truth for "tensile strength" is a measured force in MPa, which is then compared to an acceptance criterion (e.g., ≥14MPa). For chemotherapy drug permeation, the ground truth is the measured breakthrough time in minutes.

    8. The Sample Size for the Training Set

    Not applicable. This is a traditional medical device (gloves), not an AI/machine learning model. Therefore, there is no "training set." The manufacturing process for physical gloves does not involve machine learning training.

    9. How the Ground Truth for the Training Set was Established

    Not applicable, as there is no training set for a physical device like examination gloves.

    Ask a Question

    Ask a specific question about this device

    K Number
    K213051
    Date Cleared
    2021-12-18

    (87 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination gloves is a disposable device intended for medical purpose that is worn on the examiner's hand or fingers to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978-05 Standard Practice for Assessment of Medical gloves to Permeation by Chemotherapy Drugs.

    Device Description

    The subject device is single use, disposable gloves intended for medical purposes to be worn on the examiner's hands to prevent contamination between patient and examiner. The gloves are powder-free, ambidextrous with beaded cuff, blue colored, nitrile, and tested for use with chemotherapy drugs. The gloves are offered in six sizes: XS, S, M, L, XL, XXL. The subject device is non-sterile.

    AI/ML Overview

    The provided document is a 510(k) premarket notification for Nitrile Patient Examination Gloves (Tested for Use with Chemotherapy Drugs). It details the device's technical characteristics, intended use, and performance testing results to demonstrate substantial equivalence to a predicate device.

    Here's the breakdown of the acceptance criteria and study information:

    1. Table of Acceptance Criteria and Reported Device Performance

    The core performance evaluation for these gloves relates to their physical properties, freedom from holes, powder content, biocompatibility, and most importantly, resistance to permeation by chemotherapy drugs.

    Test MethodPerformance CharacteristicAcceptance CriteriaReported Device Performance
    ASTM D6319Physical Dimensions Test
    Length (mm) - XS≥220> 240/Pass
    Length (mm) - S/M/L/XL/XXL≥230> 240/Pass
    Width (mm) - XS70 ± 1067-72/Pass
    Width (mm) - S80 ± 1076-83/Pass
    Width (mm) - M95 ± 1091-99/Pass
    Width (mm) - L110 ± 10106-112/Pass
    Width (mm) - XL120 ± 10116-124/Pass
    Width (mm) - XXL130 ± 10127-134/Pass
    Thickness (mm) - Finger≥0.050.06-0.10/Pass
    Thickness (mm) - Palm≥0.050.07-0.10/Pass
    ASTM D5151Watertightness Test for Detection of HolesMeet the requirements of ASTM D5151 AQL 2.50/125/Pass (This implies 0 holes out of 125 gloves tested, meeting or exceeding AQL 2.5)
    ASTM D6124Powder ContentMeet the requirements of ASTM D6124 ≤ 2.0mg0.02mg/Pass
    ASTM D412Physical Properties (Tensile Strength & Elongation)
    Before Aging:
    Tensile Strength≥14MPa16.4-17.8MPa/Pass
    Ultimate Elongation≥500%533-551%/Pass
    After Aging:
    Tensile Strength≥14MPa15.8-16.8MPa/Pass
    Ultimate Elongation≥400%520-554%/Pass
    ISO 10993-5Biocompatibility - CytotoxicityNon- In Vitro CytotoxicityUnder conditions of the study, device extract is not cytotoxic. /Pass
    ISO 10993-10Biocompatibility - IrritationNon-irritatingUnder the conditions of the study, not an irritant. / Pass
    ISO 10993-10Biocompatibility - SensitizationNon-sensitizingUnder conditions of the study, not a sensitizer. / Pass
    **ASTM D6978-05 (Reapproved 2019) **Chemotherapy Drug Permeation (Minimum Breakthrough Detection Time)
    Carboplatin (10.0 mg/ml)N/A (Comparative to predicate)> 240 Minutes
    Carmustine (BCNU) (3.3 mg/ml)N/A (Comparative to predicate)35.2 Minutes
    Cyclophosphamide (Cytoxan) (20.0 mg/ml)N/A (Comparative to predicate)> 240 Minutes
    Doxorubicin (2.0 mg/ml)N/A (Comparative to predicate)> 240 Minutes
    Etoposide (20.0 mg/ml)N/A (Comparative to predicate)> 240 Minutes
    Fluorouracil (50.0 mg/ml)N/A (Comparative to predicate)> 240 Minutes
    Methotrexate (25.0 mg/ml)N/A (Comparative to predicate)> 240 Minutes
    Paclitaxel (6.0 mg/ml)N/A (Comparative to predicate)> 240 Minutes
    ThioTepa (10.0 mg/ml)N/A (Comparative to predicate)76.3 Minutes

    Note on Chemotherapy Permeation Acceptance Criteria: The document primarily presents these as reported values and compares them to the predicate device in Table 1 (pages 6-7). The acceptance criteria for these would implicitly be that the breakthrough times are considered sufficient for safe use, or comparable/better than the predicate for equivalent drugs, with a clear warning for drugs with low permeation times. The "Warning: Please do not use with Carmustine (BCNU) and ThioTepa" indicates that the low breakthrough times for these specific drugs are accepted with a cautionary label, rather than requiring an explicit "minimum time" acceptance criterion for regulatory clearance.

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state the total sample size for all tests performed. However, it does provide a specific sample size for one critical test:

    • Watertightness Test (ASTM D5151): 125 gloves were tested (indicated by "0/125/Pass").
    • For other tests (e.g., physical dimensions, tensile strength, powder content, biocompatibility, chemotherapy permeation), the specific number of gloves or samples tested is not explicitly stated in the provided summary, although the ASTM standards themselves would specify statistical sampling plans.
    • Data Provenance: The tests were conducted by the manufacturer, Yunnan Huazhiyuan Medical Technology Co., Ltd. The location is China. The studies are retrospective in the sense that they are conducted on manufactured devices to demonstrate compliance with standards for the 510(k) submission, rather than being part of a prospective clinical trial.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications

    This section is not applicable to this type of device and submission. The "ground truth" for the performance of these medical gloves is established through adherence to recognized international and national standards (ASTM, ISO) for physical properties, chemical resistance, and biocompatibility, as measured by laboratory equipment and procedures, not by expert human interpretation or consensus. No human "experts" are interpreting images or clinical data for this non-diagnostic device.

    4. Adjudication Method for the Test Set

    This section is not applicable. Adjudication methods like 2+1 or 3+1 are used in clinical studies, particularly in imaging or diagnostic device evaluations where multiple readers interpret data and discrepancies need to be resolved. For laboratory bench testing against physical and chemical standards, there is no human interpretation needing adjudication.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

    This section is not applicable. MRMC studies are specific to diagnostic devices, especially those involving image interpretation by multiple human readers, to assess the impact of an AI algorithm on reader performance. This device is a medical glove, a Class I non-diagnostic device, and its performance is evaluated through bench testing against established standards, not human reader studies.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    This section is not applicable. This device is not an algorithm or AI-based product. Its performance is entirely standalone in the sense that its physical and chemical properties are measured directly from the device itself.

    7. The Type of Ground Truth Used

    The "ground truth" for this device's performance is based entirely on laboratory bench testing results measured against predefined acceptance criteria established by recognized international standards (ASTM and ISO).

    • Physical properties: Measured dimensions, tensile strength, elongation.
    • Freedom from holes: Tested using a water-tightness test.
    • Powder content: Measured residual powder.
    • Biocompatibility: In vitro cytotoxicity, irritation, and sensitization tests.
    • Chemotherapy drug permeation: Measured breakthrough times using specific chemical assays as per ASTM D6978-05.

    8. The Sample Size for the Training Set

    This section is not applicable. This is a physical medical device, not an AI/ML algorithm that requires a training set. The "training" for the device's manufacturing process would be based on quality control and manufacturing specifications, not a data training set.

    9. How the Ground Truth for the Training Set Was Established

    This section is not applicable as it pertains to AI/ML devices.

    Ask a Question

    Ask a specific question about this device

    K Number
    K211914
    Date Cleared
    2021-10-14

    (115 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Nitrile Patient Examination Gloves are disposable devices intended for medical purposes that are worn on the examiner's hands to prevent contamination between patient and examiner.

    Device Description

    The proposed device is Powder Free Nitrile Patient Examination Gloves. The proposed device is blue. The design of proposed device is addressing the standards as ASTM D6124,ASTM D5151, and ASTM D6319. The proposed device is non-sterile.

    AI/ML Overview

    The provided text is a 510(k) summary for Nitrile Patient Examination Gloves (K211914). This document pertains to the regulatory clearance of a medical device, specifically patient examination gloves, and does not describe an AI/ML-based device that would require the detailed acceptance criteria and study information requested.

    Therefore, I cannot provide the information requested for the following reasons:

    1. Nature of the Device: The device described (Nitrile Patient Examination Gloves) is a physical medical device. The requested information (acceptance criteria for an AI/ML device, ground truth establishment, expert adjudication, MRMC studies, training/test set sample sizes, etc.) is specific to the development and validation of artificial intelligence and machine learning algorithms, particularly in medical imaging or diagnostic applications.
    2. Absence of AI/ML Study Data: The document outlines non-clinical performance testing for physical properties (e.g., tensile strength, freedom from holes, biocompatibility) of the gloves to demonstrate substantial equivalence to a predicate device. It explicitly states, "Clinical testing is not needed for this device." There is no mention of any AI or software components, nor studies related to their performance.

    Without information on an AI/ML component or a study designed to evaluate such a component, I cannot fulfill the request to describe acceptance criteria and the study that proves an AI/ML device meets those criteria.

    Ask a Question

    Ask a specific question about this device

    K Number
    K211434
    Date Cleared
    2021-08-05

    (87 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Nitrile Patient Examination Gloves are non-sterile disposable devices intended for medical purposes that are worn on the examiner's hands or finger to prevent contamination between patient and examiner.

    Device Description

    The subject device is powder free nitrile examination gloves. The glove is manufactured from nitrile. Inner surface of gloves undergoes surface treatment process to produce a smooth surface that assists the user in donning the gloves with ease without using any lubricant such as powder on the glove surface. The glove is ambidextrous, i.e., can be worn on right hand or left hand. The subject device is blue. The subject device is non-sterile, and single use device to prevent contamination between patient and examiner.

    The subject device can be available in six specifications: XS、S、M、L、XL and XXL.

    AI/ML Overview

    This document is a 510(k) Premarket Notification for Nitrile Patient Examination Gloves, which are Class I devices. The submission focuses on demonstrating substantial equivalence to a predicate device through non-clinical testing. It does not involve AI or complex medical imaging analysis. Therefore, many of the requested elements (e.g., number of experts, adjudication methods, MRMC studies, training set details) are not applicable to this type of medical device submission.

    Here's an analysis of the provided text in the context of the requested information, focusing on what is relevant and explicitly stated:

    Device: Nitrile Patient Examination Gloves (K211434)

    This product is a simple, non-sterile, disposable examination glove. Its acceptance criteria and performance are based on established physical, chemical, and biocompatibility standards for such devices, not on complex algorithmic performance like AI.

    1. Table of Acceptance Criteria and Reported Device Performance

    The core of the performance evaluation is found in "Table 3 Performance Comparison" and the more detailed "Test Methodology" and "Results" table within Section 8.0 "Summary of Non-clinical Testing."

    ItemTest MethodologyAcceptance CriteriaReported Device Performance/Results
    Physical DimensionsASTM D6319Length (mm): XS/S: ≥220; M/L/XL: ≥230Length: >230 (all sizes, meeting criteria)
    Width (mm): XS: 70±10; S: 80±10; M: 95±10; L: 110±10; XL: 120±10; XXL: 130±10XS: 78-80; S: 86-89; M: 97-99; L: 117-119; XL: 116-118; XXL: 128-131 (all Pass)
    Thickness (mm): Finger: ≥0.05; Palm: ≥0.05Finger: 0.07-0.13 (Pass); Palm: 0.07-0.11 (Pass)
    Physical PropertiesASTM D412Before Aging: Tensile Strength: ≥14MPa; Ultimate Elongation: ≥500%Tensile Strength: 15.2-17.6 MPa (Pass); Ultimate Elongation: 520-579% (Pass)
    After Aging: Tensile Strength: ≥14MPa; Ultimate Elongation: ≥400%Tensile Strength: 15.3-17.5 MPa (Pass); Ultimate Elongation: 519-580% (Pass)
    Freedom from HolesASTM D5151AQL=2.5 (Be free from holes when tested)2/125, 0/125, 0/125, 1/125, 0/125, 0/125 leaks (Pass)
    Powder ContentASTM D6124< 2.0mg (Meet the requirements of ASTM D6124)0.05, 0.06, 0.08, 0.07, 0.09, 0.06 mg (Pass)
    BiocompatibilityISO 10993-5Non-cytotoxicUnder conditions of the study, did not show potential toxicity to L-929 cells (Pass)
    ISO 10993-10Non-irritatingUnder conditions of the study, not an irritant (Pass)
    ISO 10993-10Non-sensitizingUnder conditions of the study, not a sensitizer (Pass)

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size: The document provides specific sample sizes for certain tests within the "Results" section of the non-clinical testing summary:
      • Watertightness Test (ASTM D5151): Indicated by "2/125, 0/125, 0/125, 1/125, 0/125, 0/125 leaks." This suggests a sample size of 125 gloves per test run, with 6 runs shown (total 750 gloves tested for holes). However, the specific methodology of ASTM D5151 for an AQL of 2.5 involves sampling plans based on lot size, which isn't detailed here beyond the reported results.
      • Powder Content (ASTM D6124): Six data points (0.05, 0.06, 0.08, 0.07, 0.09, 0.06) are reported, suggesting 6 samples were tested.
      • Physical properties (ASTM D412): Results are shown across six sizes (XS, S, M, L, XL, XXL) for a range of values. The exact number of samples tested per size is not explicitly stated but implies multiple measurements per characteristic per size.
      • Biocompatibility (ISO 10993-5, ISO 10993-10): Specific sample numbers are not provided, as these are typically conducted in accordance with the standard, which defines the test methods and sample requirements.
    • Data Provenance: Not explicitly stated, but implies the testing was conducted by the manufacturer or a contracted lab to generate data for the 510(k) submission. There is no indication of country of origin for the data itself outside of the manufacturer's location (Zhangjiagang, China). The data is by nature prospective, as it's generated specifically for the submission to prove compliance with standards.

    3. Number of Experts Used to Establish Ground Truth and Qualifications

    Not Applicable. This is not an AI/imaging device. Ground truth for these criteria (e.g., tensile strength, presence of holes, cytotoxicity) is established by adherence to globally recognized, standardized test methodologies (ASTM, ISO) and laboratory measurements, not by expert human interpretation or consensus.

    4. Adjudication Method for the Test Set

    Not Applicable. See point 3. Testing involves objective, quantitative measurements against predefined standards.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not Applicable. This is not an AI/imaging device. No human-in-the-loop study or MRMC study was performed or required.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not Applicable. This is not an AI/imaging device.

    7. The Type of Ground Truth Used

    The "ground truth" for this device is based on objective, measurable criteria defined by international standards (ASTM, ISO). For example:

    • Physical Dimensions: Measured directly using calibrated instruments against specified length, width, and thickness ranges.
    • Physical Properties (Tensile Strength, Elongation): Measured using standardized mechanical testing equipment (e.g., universal testing machine) according to ASTM D412.
    • Freedom from Holes: Determined by standardized watertightness test (filling with water and checking for leaks) according to ASTM D5151, with results evaluated against an Acceptable Quality Level (AQL).
    • Powder Content: Measured gravimetrically according to ASTM D6124.
    • Biocompatibility: Determined by laboratory tests (e.g., cell culture for cytotoxicity, animal/in-vivo tests for irritation/sensitization) according to ISO 10993 series.

    8. The Sample Size for the Training Set

    Not Applicable. This device does not involve a "training set" in the context of machine learning or AI models. It's a manufactured product whose quality is assessed through conventional engineering and biological testing.

    9. How the Ground Truth for the Training Set was Established

    Not Applicable. See point 8.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 2